| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |